Neoplasms, Basal Cell
2 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.
Broader: Neoplasms
Narrower: Carcinoma, Basosquamous 1
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Biopsy Procedure + Biospecimen Collection + Computed Tomography + Laboratory Biomarker Analysis + Positron Emission Mammography + TALIMOGENE LAHERPAREPVEC + NIVOLUMAB for carcinoma, basosquamous | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Gemcitabine + ERLOTINIB + NAB-PACLITAXEL for neoplasms, basal cell | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.